Search

everythinglearnresearchcommunity

for

Search:↓

Radiation therapy in breast cancer patients changes gene expression related to DNA damage, fibroblast growth, and hair follicle development, which could help improve treatment for radiation-induced fibrosis.

Drugs targeting EMT molecules show promise for treating lichen planopilaris.

Hair follicles and urine cell pellets are promising for transcriptome studies due to consistent quality and useful expression profiles.

Targeted cancer therapies can cause new side effects, requiring careful monitoring and management to ensure patient safety.

Intranasal delivery of gene therapy shows promise for treating ischemic stroke.

Exosomes show promise as effective treatments for autoimmune skin diseases with fewer side effects.

Targeting multiple pathways may improve treatments for androgenetic alopecia.

Small extracellular vesicles from stem and immune cells show promise for treating various diseases but face challenges in clinical use.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

CRISPR/Cas9 has improved precision and control but still faces clinical challenges.

Tumor proteins can both promote and suppress cancer, depending on the situation.

CRISPR/Cas9 and prime editing can potentially fix skin disorder genes safely and effectively.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

The model successfully predicted new uses for existing drugs, like using certain hormonal and heart medications for respiratory and Parkinson's diseases, and a cancer drug for diabetes.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

Hedgehog pathway inhibitors can treat certain aggressive cancers but face limitations like resistance and side effects.

Hair follicle analysis can track body changes from high-intensity interval training.

More precise, personalized therapies are needed for autoimmune diseases.

The lncRNA LOXL1-AS1 may help diagnose and treat androgenic alopecia.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

Targeted siRNA therapy may be a promising treatment for KID syndrome by reducing mutant gene expression and improving cell communication.

CNGA3, GLUD1, and SIRT1 are promising targets for treating aging and glioblastoma.

Exosome therapies improve skin, hair, and healing but face challenges like cost and regulation.

Drug repurposing offers promising strategies to improve tuberculosis treatment despite challenges.

Exosome therapies could help with skin and hair issues, but more testing is needed.

Quercetin delivery systems are improving its effectiveness for medical use.

Securinine and ajmaline may effectively treat liver cancer, with securinine being less toxic to normal cells.